These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1222871)

  • 41. Long-term study of oral contraception with norethindrone 2 mg. and mestranol 0.1 mg.
    Hutcherson WP; Schwartz HA; Weathers W
    Fertil Steril; 1966; 17(1):59-67. PubMed ID: 5901012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S; Zador G; Nygren KG; Wide L
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abortifacient and endocrine effects of metergoline in beagle bitches during the second half of gestation.
    Nöthling JO; Gerber D; Gerstenberg C; Kaiser C; Döbeli M
    Theriogenology; 2003 May; 59(9):1929-40. PubMed ID: 12600730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of egg development and implantation in rats after post-coital administration of the progesterone antagonist RU 486.
    Psychoyos A; Prapas I
    J Reprod Fertil; 1987 Jul; 80(2):487-91. PubMed ID: 3656280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Accumulation of norethindrone and individual metabolites in human plasma during short- and long-term administration of a contraceptive dosage.
    Braselton WE; Lin TJ; Ellegood JO; Mills TM; Mahesh VB
    Am J Obstet Gynecol; 1979 Jan; 133(2):154-60. PubMed ID: 369375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical effects of orally administered extracts of Montanoa tomentosa in early human pregnancy.
    Landgren BM; Aedo AR; Hagenfeldt K; Diczfalusy E
    Am J Obstet Gynecol; 1979 Oct; 135(4):480-4. PubMed ID: 114055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The 'pill' may inhibit early cancer, study suggests.
    JAMA; 1972 May; 220(6):775-80. PubMed ID: 12275891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma levels of progesterone during the luteal phase in normal women treated with synthetic oestrogens (RS 2874, F 6103 and ethinyloestradiol).
    Johansson ED; Gemzell C
    Acta Endocrinol (Copenh); 1971 Nov; 68(3):551-60. PubMed ID: 5171371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of two contraceptives on induction of mammary cancer in rats.
    McCarthy JD
    Am J Surg; 1965 Nov; 110(5):720-3. PubMed ID: 5862377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of the antiprogestin mifepristone (RU 486) prior to prostaglandin termination of pregnancy.
    Urquhart DR; Bahzad C; Templeton AA
    Hum Reprod; 1989 Feb; 4(2):202-3. PubMed ID: 2918074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
    Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF
    Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
    Glasier A; Thong KJ; Dewar M; Mackie M; Baird DT
    N Engl J Med; 1992 Oct; 327(15):1041-4. PubMed ID: 1522839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Failure of large doses of ethinyl estradiol to interfere with early embryonic development in the human species.
    Bacic M; Wesselius de Casparis A; Diczfalusy E
    Am J Obstet Gynecol; 1970 Jun; 107(4):531-4. PubMed ID: 5423572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Letter: The effect of contraceptive steroids on carbohydrate metabolism.
    Davidson MB
    Metabolism; 1974 Jul; 23(7):687-90. PubMed ID: 4834911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Excretion of 17-hydroxycorticosteroids under the effect of combined preparations containing separate progestagens: ethynodiol diacetate and chlormadinone].
    Kloś J; Radwańska E
    Endokrynol Pol; 1971; 22(1):61-8. PubMed ID: 4100342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of 7 alpha- and 7 beta-methyl-10 beta, 17 beta-diacetoxy-delta 4-estren-3-one on terminating early pregnancy].
    Chu YH; Zhao ZF; Qian YX; Bao YM
    Yao Xue Xue Bao; 1984 Mar; 19(3):173-7. PubMed ID: 6548598
    [No Abstract]   [Full Text] [Related]  

  • 58. Dynamic testing of hypothalamic-pituitary function in abnormalities of ovulation.
    Jones GE; Wentz AC; Rosenwaks Z; Shoemaker J
    Am J Obstet Gynecol; 1977 Dec; 129(7):760-76. PubMed ID: 343592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On the mechanism of action of oral contraceptives. I. Effect of lynestrenol on ovum implantation and oviductal morphology in the rat.
    Castro-Vazquez A; Macome JC; de Carli DN; Rosner JM
    Fertil Steril; 1971 Nov; 22(11):741-4. PubMed ID: 5123249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
    Weikel JH; Nelson LW
    J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.